DIABETES RESEARCH AND CLINICAL PRACTICE

Scope & Guideline

Exploring breakthroughs in endocrinology and diabetes care.

Introduction

Welcome to the DIABETES RESEARCH AND CLINICAL PRACTICE information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of DIABETES RESEARCH AND CLINICAL PRACTICE, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0168-8227
PublisherELSEVIER IRELAND LTD
Support Open AccessNo
CountryIreland
TypeJournal
Convergefrom 1985 to 2024
AbbreviationDIABETES RES CLIN PR / Diabetes Res. Clin. Pract.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE 00000, IRELAND

Aims and Scopes

The journal 'Diabetes Research and Clinical Practice' primarily focuses on advancing the understanding, prevention, and management of diabetes through innovative research and clinical practices. It aims to disseminate high-quality studies that enhance clinical outcomes for patients with diabetes and related metabolic disorders.
  1. Clinical and Epidemiological Research:
    The journal publishes studies that explore the clinical aspects of diabetes, including epidemiological trends, risk factors, and the impact of diabetes on overall health outcomes.
  2. Innovative Treatment Approaches:
    Research on novel therapeutic strategies, including pharmacological treatments, dietary interventions, and lifestyle modifications aimed at improving glycemic control and patient quality of life.
  3. Diabetes Complications and Comorbidities:
    Articles focusing on the prevention, diagnosis, and management of diabetes-related complications such as cardiovascular disease, kidney disease, and neuropathy.
  4. Patient-Centered Care:
    Studies emphasizing the importance of patient engagement, education, and self-management strategies in diabetes care.
  5. Health Policy and Economic Evaluations:
    Research assessing the implications of health policies on diabetes management, including cost-effectiveness analyses of treatments and interventions.
  6. Technological Advancements in Diabetes Management:
    Exploration of digital health tools, continuous glucose monitoring systems, and telemedicine in managing diabetes effectively.
Recent publications in 'Diabetes Research and Clinical Practice' indicate a shift towards several emerging themes that are gaining traction in diabetes research. These trends reflect the evolving landscape of diabetes care and the need for more comprehensive approaches to management.
  1. Digital Health Technologies:
    There is an increasing focus on the integration of digital tools, such as mobile health applications and telemedicine, in diabetes management, reflecting the need for accessible and patient-centered care.
  2. Personalized Medicine Approaches:
    Emerging research is emphasizing personalized treatment plans based on individual patient profiles, including genetic, metabolic, and lifestyle factors, to optimize diabetes management.
  3. Mental Health and Diabetes:
    The intersection of mental health, diabetes distress, and patient outcomes is gaining attention, highlighting the importance of psychological well-being in managing diabetes.
  4. Diabetes and Cardiovascular Risk Management:
    A growing body of research is examining the link between diabetes and cardiovascular disease, with studies focusing on prevention and management strategies for at-risk populations.
  5. Longitudinal Studies on Diabetes Progression:
    Emerging interest in long-term studies that track the progression of diabetes and its complications over time, providing insights into effective management strategies.

Declining or Waning

Over recent years, certain themes in diabetes research appear to be losing prominence or frequency in publications. This may reflect shifts in research priorities, funding, or emerging areas of interest that overshadow previously popular topics.
  1. Traditional Dietary Interventions:
    There seems to be a decline in studies focusing solely on traditional dietary approaches to diabetes management, as more attention shifts towards integrative and personalized nutrition strategies.
  2. Single-Drug Efficacy Studies:
    Research concentrating on the efficacy of single-drug treatments is waning, likely due to a growing focus on combination therapies and multi-faceted treatment approaches.
  3. Basic Science Research in Diabetes:
    While foundational research remains important, there is a noticeable shift towards clinical and translational studies that directly impact patient care and outcomes.
  4. General Public Awareness Campaigns:
    The emphasis on broad public awareness campaigns about diabetes is decreasing, possibly due to a pivot towards targeted interventions that address specific populations or high-risk groups.

Similar Journals

Cardiovascular Diabetology

Exploring the Nexus of Heart Health and Diabetes Care
Publisher: BMCISSN: Frequency: 1 issue/year

Cardiovascular Diabetology is a prestigious open-access journal published by BMC, focusing on the intersecting fields of cardiology, endocrinology, diabetes, and internal medicine. Since its inception in 2002, this journal has established itself as a vital resource for researchers, clinicians, and academics dedicated to advancing knowledge in these areas. With an impressive impact factor reflected in its Q1 rankings for the year 2023 across its respective categories, including a ranking of 22nd in Cardiology and Cardiovascular Medicine and notably 15th in Internal Medicine, it positions itself at the forefront of scholarly communication. The journal encourages the dissemination and sharing of groundbreaking research, providing open access to foster engagement and collaboration among professionals globally. As it converges from 2002 to 2024, Cardiovascular Diabetology continues to be a pivotal platform for innovative studies, reviews, and critical insights that significantly impact clinical practices and medical education in the evolving landscape of cardiovascular health and diabetes management.

DIABETES OBESITY & METABOLISM

Bridging science and clinical practice in metabolic health.
Publisher: WILEYISSN: 1462-8902Frequency: 12 issues/year

DIABETES OBESITY & METABOLISM, published by Wiley, is a premier international journal dedicated to the fields of endocrinology, diabetes, and metabolic disorders. With an impressive impact factor and its status as a Q1 journal in multiple categories—including Endocrinology and Internal Medicine—this publication is highly regarded in the academic community. Since its inception in 1999, the journal has served as a crucial platform for the dissemination of cutting-edge research, reviews, and clinical studies, driving advancements in understanding and treatment of diabetes and obesity. Researchers and professionals alike benefit from its rigorous peer-review process and extensive reach, as it aims to bridge the gap between laboratory findings and clinical applications. Although not an Open Access journal, articles are accessible through institutional subscriptions, ensuring that vital knowledge reaches those committed to enhancing patient care and expanding the scientific body of work in these pivotal areas.

Diabetes Epidemiology and Management

Pioneering the Future of Diabetes Management
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Diabetes Epidemiology and Management, published by Elsevier, is an innovative open-access journal that has been addressing the critical issues surrounding diabetes since its inception in 2021. This journal integrates a comprehensive exploration of the epidemiology, prevention, and management of diabetes, making it a pivotal resource within the fields of Endocrinology, Diabetes and Metabolism, and Internal Medicine. With a digital presence represented by E-ISSN 2666-9706, it currently holds a commendable position in the academic landscape, categorized in the Q3 quartile for both Endocrinology and Internal Medicine as per the 2023 metrics. The journal aims to enhance understanding and promote research on diabetes, offering authors a platform to share their findings with a global audience. Researchers, professionals, and students alike can benefit from this essential resource, which is dedicated to advancing the knowledge base and improving clinical practices in diabetes management. With open access options since 2021, the journal ensures that vital research is widely accessible, driving innovation and collaboration in the fight against diabetes.

Journal of Diabetes

Advancing diabetes research for a healthier tomorrow.
Publisher: WILEYISSN: 1753-0393Frequency: 12 issues/year

The Journal of Diabetes, published by WILEY, is a premier Open Access platform since 2022, dedicated to advancing knowledge in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 1753-0393 and an E-ISSN of 1753-0407, this journal provides a vital resource for researchers and practitioners looking to keep up with the latest findings and trends in diabetes management and treatment. As of 2023, it holds a commendable Q2 rating in its category and ranks #78 out of 244 in the Scopus classification, placing it in the 68th percentile, thus affirming its significance in the academic community. Covering a timeline from 2009 to 2024, the journal invites submissions that contribute to the understanding of diabetes pathophysiology, innovative therapies, and clinical practices, making it an essential read for anyone dedicated to improving patient outcomes in diabetes care.

Cardiovascular Journal of Africa

Transforming cardiovascular care through shared knowledge.
Publisher: CLINICS CARDIVE PUBL PTY LTDISSN: 1995-1892Frequency: 6 issues/year

Welcome to the Cardiovascular Journal of Africa, an esteemed publication dedicated to advancing the fields of Cardiology and Cardiovascular Medicine. Established in 1994 and published by CLINICS CARDIVE PUBL PTY LTD, this journal serves as a vital platform for researchers, practitioners, and students interested in innovative cardiovascular research and clinical practice within the African context and beyond. With a Q3 ranking in both relevant categories as of 2023, this journal contributes significantly to the growing corpus of medical literature. Although access is non-open, the journal features a diverse array of peer-reviewed articles that explore groundbreaking findings and practical applications in cardiovascular health, fostering knowledge exchange among professionals. Situated in South Africa, the Cardiovascular Journal of Africa is not just a repository of academic research; it is a cornerstone in the fight against cardiovascular diseases, addressing the unique challenges faced by populations across the continent.

Journal of Clinical and Translational Endocrinology

Pioneering Research for Tomorrow's Endocrine Practices.
Publisher: ELSEVIERISSN: 2214-6237Frequency: 4 issues/year

Journal of Clinical and Translational Endocrinology is a peer-reviewed open access journal published by Elsevier that has been serving the endocrinology community since its inception in 2014. With an ISSN of 2214-6237, this journal focuses on the critical intersection of clinical and translational research in endocrinology, diabetes, and metabolism, offering insights that bridge laboratory discoveries with patient care. It holds a commendable position in the field, ranking Q3 for Endocrinology and Q2 for Endocrinology, Diabetes, and Metabolism, reflecting its rigorous standards and relevance to contemporary research. Situated in the Netherlands, the journal’s aim is to foster knowledge dissemination and collaboration among professionals, researchers, and students alike, ensuring high visibility in a rapidly evolving field. The journal is committed to open access, allowing immediate access to research findings, thus maximizing their impact and facilitating advancements in clinical practice and research. With an H index that showcases its contribution to the field, Journal of Clinical and Translational Endocrinology is an essential resource for anyone invested in advancing endocrinological science.

Diabetology International

Elevating knowledge, enhancing diabetes care.
Publisher: SPRINGER JAPAN KKISSN: 2190-1678Frequency: 4 issues/year

Diabetology International, published by Springer Japan KK, is a leading journal dedicated to the field of diabetes research. With an ISSN of 2190-1678 and E-ISSN of 2190-1686, this journal plays a pivotal role in disseminating innovative studies and findings that advance understanding in endocrinology, diabetes, and metabolism. Its rigorous peer-review process ensures the publication of high-quality research articles, review papers, and clinical studies, making it a valuable resource for researchers, healthcare professionals, and students. The journal is indexed in Scopus and maintains respectable rankings in its categories, standing at Q3 in Endocrinology, Diabetes and Metabolism, and Q2 in Internal Medicine as of 2023. Furthermore, the journal facilitates collaborations and promotes the exchange of ideas from its base in Tokyo, Japan, helping to bridge the gap between academia and clinical practice. As it converges through the years from 2010 to 2024, Diabetology International remains committed to addressing the evolving challenges in diabetes care and research, supporting the global community's pursuit of knowledge in this crucial field.

CURRENT DIABETES REVIEWS

Cutting-edge Reviews for Diabetes Research
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-3998Frequency: 9 issues/year

CURRENT DIABETES REVIEWS is a leading academic journal published by Bentham Science Publishers Ltd, dedicated to disseminating high-quality reviews and cutting-edge insights in the field of Endocrinology, Diabetes and Metabolism. Established in 1996 and actively publishing from 2005 to 2024, this journal holds a prestigious position within the academic community, evidenced by its Q2 ranking in both relevant categories for 2023 and its impactful presence in Scopus, where it ranks #83 out of 244 in Endocrinology and Diabetes and Metabolism. Despite being a subscription-based journal, it provides researchers, healthcare professionals, and students with valuable contributions that significantly advance the understanding of diabetes and related metabolic disorders. With a commitment to promoting interdisciplinary collaboration and innovation, CURRENT DIABETES REVIEWS serves as an essential resource for those seeking to stay abreast of the latest developments in diabetes research and therapies.

Practical Diabetes

Exploring innovative strategies in diabetes management.
Publisher: JOHN WILEY & SONS LTDISSN: 2047-2897Frequency: 9 issues/year

Practical Diabetes is an esteemed journal dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Published by John Wiley & Sons Ltd, this journal serves as a vital resource for healthcare professionals, researchers, and students seeking to explore the latest findings and practical applications in the field of endocrinology. With an ISSN of 2047-2897, it has established itself as a respected outlet for impactful research since its inception in 2011, with a convergence period extending until 2024. Although currently listed in Q4 for Endocrinology, Diabetes, and Metabolism and Q3 for Internal Medicine, the journal is committed to improving its rank and increasing its relevance in a competitive academic landscape. While not an open-access publication, Practical Diabetes provides valuable insights and evidence-based practices that are crucial for improving patient outcomes. Researchers and practitioners alike will find a wealth of knowledge to inform their work and enhance their understanding of diabetes management, making this journal an essential addition to any academic library collection.

Metabolic Syndrome and Related Disorders

Unveiling Insights into Metabolic Syndrome
Publisher: MARY ANN LIEBERT, INCISSN: 1540-4196Frequency: 10 issues/year

Metabolic Syndrome and Related Disorders is an esteemed journal published by MARY ANN LIEBERT, INC, focusing on the multifaceted aspects of metabolic syndrome, including its interaction with chronic diseases such as diabetes, cardiovascular conditions, and obesity. Since its inception in 2003, this journal has established itself as a vital resource for researchers, healthcare professionals, and students dedicated to advancing knowledge in the fields of endocrinology, internal medicine, and metabolic disorders. With an impact factor reflective of its academic significance, Metabolic Syndrome and Related Disorders is recognized within the Q2 and Q3 quartiles in its respective categories, solidifying its reputation among scientific and clinical communities. Although it does not currently offer open access options, the journal remains committed to disseminating high-quality research and reviews that foster innovative solutions and improve patient outcomes. The journal's gradual convergence towards 2024 presents an exciting opportunity for continued exploration and dialogue about metabolic-related health challenges.